Top Markets
Coin of the day
Safeguard Scientifics, Inc. Safeguard Scientifics, Inc.

Safeguard Scientifics, Inc.

SFE
Hisse Senetlerindeki Sıralama #30774
Safeguard Scientifics, Inc., while no longer actively pursuing new investments,... Safeguard Scientifics, Inc., while no longer actively pursuing new investments, previously functioned as a private equity and venture capital firm. It specialized in diverse funding approaches, including expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, and both growth-stage and early-stage investments. Initial investments typically targeted Series A through C funding rounds, with opportunistic engagement in seed-stage opportunities. The firm primarily directed its capital towards companies in the technology, financial services, and healthcare sectors. Within technology, its interests encompassed Software-as-a-Service (SaaS), adtech/digital media, the Internet of Everything (IoE), advanced security solutions, predictive analytics, machine learning, artificial intelligence, enterprise software, technology-enabled services, internet/new media, financial technology (fintech), cloud computing, mobile applications, social platforms, big data, in-memory computing, and select business services, often requiring up to $25 million in capital. In healthcare, Safeguard Scientifics backed ventures in molecular and point-of-care diagnostics, medical devices, regenerative medicine, broader medical technology, digital health, healthcare technology, specialty pharmaceuticals, and certain healthcare service providers. Geographically, the firm invested across the entire United States, with a particular focus on the Mid-Atlantic region, and also extended its reach to Southeastern Canada. Its typical investment sizes ranged from $5 million to $25 million for growth equity rounds, and between $5 million and $10 million for early-stage financing. Safeguard Scientifics commonly provided capital to a diverse array of entities, ranging from owner-financed or bootstrapped enterprises and corporate divisions to venture capital-backed companies seeking a strategic growth partner. Ideally, the firm aimed to be the largest shareholder in its portfolio companies, typically securing an ownership stake between 20% and 50%, although it occasionally took either a majority or a smaller position. A strong preference was given to companies leveraging proprietary technology and intellectual property. Furthermore, the firm generally pursued a board seat in its funded companies. Established in 1953 as Lancaster Corporation, the company officially adopted the name Safeguard Scientifics, Inc. in 1981. Its main office is situated in Radnor, Pennsylvania, complemented by an additional location in Weston, Massachusetts.
Hisse Fiyatı
$0.75
Son senkronizasyon: 2024-03-08
Piyasa Değeri
$15.59M
Değişim (1 gün)
0.00%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Safeguard Scientifics, Inc. (SFE)
Safeguard Scientifics, Inc. (SFE) için F/K oranı
2026 itibarıyla F/K oranı TTM: 0
Safeguard Scientifics, Inc. şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/E oranı (TTM) 0'dir. 2026 yılının sonunda şirketin P/E oranı 0 idi.
Safeguard Scientifics, Inc. için P/E oranı geçmişi 2026 - 2026 arası
Her yıl sonunda P/E oranı
Yıl F/K Oranı Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için P/E oranı
Şirket P/E Oranı P/E Oranı Farkı Ülke
27.69 -
US
31.99 -
US
- -
SE
33.93 -
US
31.21 -
US
P/E oranı nasıl okunur?

Fiyat/Kazanç oranı (P/E) bir şirketin hisse senedi fiyatı ile hisse başına kazancı arasındaki ilişkiyi ölçer.
Düşük ancak pozitif bir P/E, şirketin mevcut değerlemesine göre yüksek kâr elde ettiğini ve düşük değerlenmiş olabileceğini gösterir. Yüksek negatif (0'a yakın) bir P/E ciddi zararlar anlamına gelir.

P/E oranı 30'un üzerinde veya negatif olan şirketler genellikle "büyüme hisseleri" olarak görülür, yani yatırımcılar şirketin büyümesini veya kârlı hale gelmesini bekler.

Pozitif P/E oranı 10'un altında olan şirketler genellikle "değer hisseleri" olarak değerlendirilir, yani şirket zaten çok kârlıdır ancak büyük bir büyüme beklenmez.